Why come to UChicago Medicine for arrhythmia treatment? One, the true collaborative spirit of our team. When you come and see any one of us, you get a whole team approach. Two, we really embrace innovation. We are looking on a daily basis to find new techniques for problems that cannot be solved with traditional methods. And three, as a major academic center, we will often get the earliest release of the latest technologies, and we serve as the national and global site for multiple randomized clinical studies.
In the August 31 issue of Science Translational Medicine, new research from the University of Chicago shows how deficits in a specific pathway of genes can lead to the development of atrial fibrillation, a common irregular heartbeat, which poses a significant health risk. Researchers describe a complex system of checks and balances and offer insights that could lead to individualized treatment in humans.